Tags » New England Journal Of Medicine

Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage by Prof. Hans Christophe Diener

Hans Christophe Diener discusses the treatment of patients with intracerebral hemorrhage.

The ATACH-II (Antihypertensive Treatment of Acute Cerebral Hemorrhage II) trial — showing that very intensive blood pressure reduction is no better than standard blood pressure lowering in the emergency treatment of patients with acute hemorrhagic stroke — has now been  727 more words

Meet The Experts

Vitamin D deficiency is widely overestimated, doctors warn

Doctors are warning about vitamin D again, and it’s not the “we need more” news you might expect. Instead, they say there’s too much needless testing and too many people taking too many pills for a problem that few people truly have. 697 more words

U.S. News

Bryan Podcast: Episode 5

In this episode we cover the race baiting that has gone in in the New England Journal of Medicine. Warning! The podcast is up to an hour long, is tangential and also contains personal anecdotes and light politics. 21 more words

Clinical Innovation

Clinical Trial Data Sharing Off to a Slow Start: A Rutgers paper in The New England Journal of Medicine explores why long-awaited access to drug trial data is underused

Clinical data-sharing is touted as key to accelerating medical discoveries, but a two-year-old sharing program is surprisingly underused.

For many years, doctors, scientists and researchers have urged that clinical drug trial data be shared to accelerate medical advances in treating multiple diseases. 194 more words

Rutgers Research

Scientists found the gene that controls body awareness, a sort of human ‘sixth sense’

Body awareness, or proprioception, helps us navigate space and relate to the world around, just like vision or hearing or touch. It’s a sort of sixth sense that works in conjunction with the rest—and has now been linked to a specific gene in humans, PIEZO2. 447 more words

Results from phase 3 FRAME study of romosozumab showed significant reductions in both new vertebral and clinical fractures in postmenopausal women with osteoporosis

FRAME Data Simultaneously Published in New England Journal of Medicine and Presented at ASBMR Showed Treatment With Romosozumab Significantly Reduced New Vertebral and Clinical Fractures Through 12 Months Significant Bone Mineral Density Gains Shown at Six and 12 Months at the Lumbar Spine, Total Hip and Femoral Neck… 1,600 more words



The deviousness of corporate greed knows no end. Check out what the sugar industry has been up to, leading us all down the garden path with our health. 293 more words